SaMD as an Accessory to a Medical Device

Definition and Regulatory Implications

Software as a Medical Device (SaMD) can exist not only as a standalone medical tool but also as an accessory to a physical medical device. In this role, the software is not intended to operate independently but to support, drive, or supplement the primary device’s function.

From a regulatory perspective, accessories are subject to the same level of scrutiny as the devices they accompany. In some cases, the accessory may even fall into a higher risk class if it directly influences diagnosis, treatment, or patient safety.

• EU MDR.
  The European Medical Device Regulation explicitly covers accessories, classifying them separately. Manufacturers must demonstrate that the accessory complies with MDR requirements, including safety, performance, and labeling.

• FDA.
  The U.S. Food and Drug Administration defines accessories as articles intended to support, supplement, or augment a parent device. Depending on risk, they may be reviewed under the same clearance pathway as the parent device or require a separate submission (510(k), De Novo, or PMA).

• General Principle.
  Even if the parent device is already certified, the accessory must meet its own regulatory requirements, ensuring interoperability, cybersecurity, and patient safety.

Examples of SaMD Accessories

Regulators typically evaluate the intended use and degree of integration with the main device to determine whether a piece of software qualifies as an accessory or a standalone SaMD. Common examples include:

• Mobile applications that monitor or adjust infusion pumps or insulin delivery systems.

• Software dashboards that allow clinicians to program pacemakers or implantable defibrillators.

• Algorithms that analyze ECG signals and automatically generate alerts for healthcare professionals.

• Decision-support tools that calculate dosage recommendations based on input from diagnostic devices.

• Cloud platforms that collect, aggregate, and display data from wearable medical devices for patient monitoring.

Each of these examples illustrates that accessories can play a critical role in ensuring the safety, effectiveness, and usability of the parent device.

Considerations for Developers

Developers working on SaMD accessories must carefully address several regulatory and technical issues:

1. Documentation.
   Accessories should either be included in the technical file of the parent device or submitted through a separate regulatory pathway. Omissions can lead to delays, non-compliance findings, or outright rejection.
2. Interoperability and Safety.
   Accessories must seamlessly integrate with the parent device, ensuring that software updates, hardware changes, or cybersecurity patches do not compromise functionality.
3. Cybersecurity.
   Since many accessories involve data transfer (e.g., via Bluetooth, Wi-Fi, or cloud), robust cybersecurity measures are essential to protect patient information and prevent device manipulation.
4. Functional Dependence.
   If the accessory directly alters or drives the main device’s function, it may be considered an integral part of the medical device system, triggering stricter classification and review.

Conclusion

SaMD accessories are becoming increasingly important in modern healthcare, particularly as medical devices shift toward connected ecosystems and digital health integration. For manufacturers, understanding the regulatory implications of accessories is critical to achieving timely approvals and maintaining compliance.

While accessories are designed to support parent devices, regulators treat them as independent regulated products, requiring their own safety, performance, and compliance evidence. By addressing interoperability, cybersecurity, and documentation early in development, companies can streamline certification and ensure safer, more effective solutions for patients and healthcare providers.